Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2003
10/29/2003EP1355641A2 Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1257527B1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands
10/29/2003EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/29/2003EP1107940B1 Vitamin d3 mimics
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP1007093B1 Treatment of disorders using interleukin-9
10/29/2003EP0996728B1 IMPROVED ANTI-IgE ANTIBODIES AND METHODS OF IMPROVING ANTIBODIES
10/29/2003EP0920322B9 Use of modified autologous blood for the treatment of autoimmune diseases
10/29/2003EP0633881B1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
10/29/2003EP0444186B2 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
10/29/2003CN1452636A Human monoclonal antibodies to dendritis cells
10/29/2003CN1452634A HLA binding peptides and their uses
10/29/2003CN1452633A Mammalian genes, related reagent and methods
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1452496A Use of strains of parapox ovis virus against organ fibrosis
10/29/2003CN1452495A Vaccine against microbial pathogens
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452488A Treatment of inflammatory disorders
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451433A Shenji ointment and preparing process thereof
10/29/2003CN1451389A Agent for promoting cell activation for external use
10/29/2003CN1125823C Ganciclovir sodium hydrate and its preparing process and application
10/29/2003CN1125651C Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/29/2003CN1125650C Human immunization strengthening medicine
10/28/2003US6639111 Bind on EP4 subtype receptor selectively and binds on the other subtype receptors weakly; side-effect reduction; autoimmune diseases; asthma; bone disorders; degenerative nerve diseases; sleeping disorders; anticoagulants
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638939 6,7-dimethoxyquinazolines and therapeutic use thereof
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638914 Pharmaceutical administration of adenosine agonists
10/28/2003US6638913 Concentrated injection and infusion solution for intravenous administration
10/28/2003US6638530 N-(2-anilino)- and pyridino- substituents; mixed with polyoxyethylene glycol and surfactant, mineral acid salt of amino acid or propylene carbonate; absorbability; anticarcinogenic agents, immunosuppressants
10/28/2003US6638525 Pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
10/28/2003US6638524 Cosmetics, foods and beverages supplemented with purified strictinin
10/28/2003US6638522 Carrier comprising solubilizing amount of propylene glycol monoester of C6-C18 fatty acid and nonionic surfactant
10/28/2003US6638500 Polyol-IFN-βconjugates modified at Cys-17 and composition containing same
10/28/2003CA2213099C S-(+)-adenosylmethionine and 3'-azido-2',3'-dideoxy-nucleoside complexes as potent inhibitors of hiv-replication
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087319A2 Carcinoembryonic antigen cell adhesion molecule 1 (ceacam1) structure and uses thereof in drug identification and screening
10/23/2003WO2003087296A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087161A1 Modified factor viii
10/23/2003WO2003087126A2 Heteroclitic analogs and related methods
10/23/2003WO2003087092A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
10/23/2003WO2003087090A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003WO2003087089A1 Piperidine derivatives having ccr3 antagonism
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087072A1 Therapeutic agent for endothelial disorder
10/23/2003WO2003087071A1 Sulfonamide derivatives
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003087060A1 Fredericamycin derivatives
10/23/2003WO2003086563A2 Diabetes imaging probes
10/23/2003WO2003086473A1 Mycoplasma polypeptides
10/23/2003WO2003086463A1 Remedies for pemphigus containing cd40l antagonist as the active ingredient
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086455A1 Immunoadjuvant
10/23/2003WO2003086454A1 Antigen-loaded chitosan microparticles for oral vaccination
10/23/2003WO2003086435A1 Cleanser
10/23/2003WO2003086425A1 An anti-rheumatism medicament and method to prepare thereof
10/23/2003WO2003086421A1 External preparations for enhancing cell activity
10/23/2003WO2003086396A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003WO2003086395A1 Tyrosine kinase inhibitors
10/23/2003WO2003086391A1 New use
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086386A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/23/2003WO2003086380A1 Ptx3 gene expression suppressing method
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003WO2003086325A2 Cyanamides useful as reversible inhibitors of cysteine proteases
10/23/2003WO2003086324A2 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003WO2003086317A2 Protein a compositions and methods of use
10/23/2003WO2003086315A2 Tyrosine kinase inhibitors
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2003086309A2 NF-κB INHIBITORS
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003086280A2 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003086097A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003054193A3 Raf/ras binding compounds
10/23/2003WO2003045523A3 Therapeutic coating for an intravascular implant
10/23/2003WO2003040164A3 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/23/2003WO2003029410A3 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
10/23/2003WO2003022255A3 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
10/23/2003WO2003016469A3 Chemo-enzymatic synthesis of sialylated oligosaccharides
10/23/2003WO2003016248A3 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
10/23/2003WO2003010201A3 Blood group antigen fusion polypeptides and methods of use thereof
10/23/2003WO2003000922A3 Chimeric immunomodulatory compounds and methods of using the same
10/23/2003WO2002081521A8 Osteoprotegerin in milk
10/23/2003WO2002081519A3 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002074034A3 Novel medicament compositions based on anticholinergic agents and endothelin antagonists
1 ... 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 ... 1172